Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferinject in Cancer Patients With Anemia
NCT04187716Phase 3Unknown
- Sponsor
- Samsung Medical Center
- Start
- Feb 2020
- Primary completion
- Dec 2020
- Countries
- 1
01
Overview
A Phase 3 trial of ferric carboxymaltose in anemia, sponsored by Samsung Medical Center. Status: unknown.
02
Drugs
ferric carboxymaltose
03
Conditions
anemia
Beyond the preview
Go deeper on NCT04187716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04187716.